Transition from Clinical Trials to RWE in Plaque Psoriasis, Psoriatic Arthritis & Rheumatoid Arthritis

Overview

From Clinical Trials to RWE in PsO, PsA and RA

This Activity for

• Resident / Fellow
• Physician
• Pharmacy

What I will learn?

•Present current scientific evidence, including clinical trials, Real-world data, and illustrative case studies, on the management of PsO, PsA and RA.
•Communicate Ixekizumab and Baricitinib value proposition to highlight what the product may mean to people living with Plaque Psoriasis (PsO), Psoriatic Arthritis (PsA) & Rheumatoid Arthritis (RA) respectively.

About Organizer

• Virtual Medical Academy

Additional items to the activity

Optional Details	Type	Fee
Transition from Clinical Trials to RWE in Plaque Psoriasis, Psoriatic Arthritis & Rheumatoid Arthritis Certificate	Certificate	Free

VAT 15% Included